The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional) |
93.286 |
PAR-18-205 |
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional) |
93.866 |
PAR-18-029 |
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) - (Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839 |
RFA-HL-18-026 |
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed |
93.846, 93.866 |
PA-18-409 |
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed |
93.846, 93.866 |
PA-18-408 |
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-18-410 |
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required |
93.233, 93.340, 93.837, 93.838, 93.839 |
PAR-18-407 |
Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-18-020 |
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-18-406 |
Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) |
93.866 |
RFA-AG-18-019 |
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed) |
93.865 |
PAR-18-333 |
Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
93.113 |
RFA-ES-18-001 |
Immunity in the Elderly (R01) Clinical Trial Optional |
93.121, 93.855, 93.866 |
RFA-AI-17-037 |
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) |
93.866 |
PAR-18-326 |
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) |
93.866 |
PAR-18-329 |
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed) |
93.173, 93.233, 93.242, 93.279, 93.307, 93.399, 93.837, 93.838, 93.839, 93.840, 93.866, 93.879 |
PAR-18-331 |
Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01-Clinical Trial Required) |
93.847 |
PA-18-330 |
NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG1) |
93.394, 93.395 |
RFA-CA-17-059 |
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) |
93.855 |
RFA-AI-17-034 |
Human Tumor Atlases (HTA) Research Centers (U2C) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-17-034 |
Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) |
93.350 |
PAR-18-332 |
Human Tumor Atlases (HTA) Precancer Atlas Research Centers (U2C) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-17-035 |
NHLBI Program Project Applications (P01 - Clinical Trials Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-18-405 |
Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed) |
93.859 |
RFA-GM-18-001 |
Human Tumor Atlas Network: Data Coordinating Center (U24) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-17-036 |
Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01-Clinical Trial Optional) |
93.173, 93.865 |
PA-18-316 |
Limited Competition: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10) |
93.394, 93.395 |
RFA-CA-17-058 |
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10) |
93.394, 93.395 |
RFA-CA-17-056 |
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10) |
93.394, 93.395 |
RFA-CA-17-057 |
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1) |
93.394, 93.395 |
RFA-CA-17-061 |
Limited Competition: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24) |
93.394, 93.395 |
RFA-CA-17-060 |
Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24) |
93.353, 93.394, 93.395 |
RFA-CA-17-044 |
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24) |
93.353, 93.394 |
RFA-CA-17-039 |
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) |
93.353, 93.394 |
RFA-CA-17-038 |
Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21-Clinical Trial Optional) |
93.173, 93.865 |
PA-18-328 |
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) (UG3/UH3) |
93.273, 93.307, 93.865 |
RFA-HD-18-032 |
Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24) |
93.395 |
RFA-CA-17-043 |
Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1) |
93.395 |
RFA-CA-17-042 |
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) |
93.213, 93.273, 93.279, 93.307, 93.393, 93.865, 93.866 |
PAR-18-324 |
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) |
93.393, 93.394, 93.395 |
RFA-CA-17-033 |
Search Results 5161-5200 of 14606 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |